Physician profile
Andrea Abbott
NPI 1245473354
$37,522.19
in general payments reported to CMS, 2019-2025
14 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $62.37 · 2021: $104 · 2022: $190 · 2023: $1,312 · 2024: $5,279 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $4,763 · Travel and Lodging: $3,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,750.00 |
| Food and Beverage | $4,763.41 |
| Travel and Lodging | $3,205.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $28,329.62 | 2024-2025 | Molli, Dermacell, Spy-Phi System |
| Molli Surgical (US) INC | $5,974.29 | 2023-2024 | |
| Dilon Technologies, INC. | $1,483.88 | 2025 | Hemoblast Bellows |
| Ethicon US, LLC | $625.91 | 2019-2023 | Stratafix, Dermabond Prineo, Echelon Endopath |
| Acera Surgical, INC. | $527.65 | 2021-2025 | Restrata Wound Matrix |
| Kerecis Limited | $144.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $125.12 | 2023 | Plasmablade(Tm) |
| Intuitive Surgical, INC. | $96.15 | 2019-2020 | |
| Iovance Biotherapeutics, INC. | $58.10 | 2025 | Amtagvi |
| Conmed Corporation | $43.05 | 2021 | |
| Surgalign Spine Technologies, INC. | $42.73 | 2019 | |
| Depuy Synthes Sales INC. | $41.02 | 2023 | Xcm Biologic Tissue Matrix, Zipfix, Matrixrib |
| Seagen INC. | $15.50 | 2023 | Tukysa |
| Delcath Systems | $15.10 | 2024 | Hepzato Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Abbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.